Compare CLDX & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | SYBT |
|---|---|---|
| Founded | N/A | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | SYBT |
|---|---|---|
| Price | $25.87 | $66.72 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $44.10 | ★ $83.67 |
| AVG Volume (30 Days) | ★ 718.4K | 187.0K |
| Earning Date | 11-10-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | N/A | ★ 26.16 |
| EPS | N/A | ★ 4.58 |
| Revenue | $2,599,000.00 | ★ $378,633,000.00 |
| Revenue This Year | N/A | $17.26 |
| Revenue Next Year | $19.70 | $5.29 |
| P/E Ratio | ★ N/A | $14.98 |
| Revenue Growth | N/A | ★ 14.11 |
| 52 Week Low | $14.40 | $60.75 |
| 52 Week High | $30.50 | $83.83 |
| Indicator | CLDX | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 47.79 |
| Support Level | $24.97 | $67.57 |
| Resistance Level | $28.79 | $69.87 |
| Average True Range (ATR) | 1.36 | 1.60 |
| MACD | -0.36 | 0.09 |
| Stochastic Oscillator | 16.46 | 26.05 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.